Where Doximity Stands With Analysts
Within the last quarter, Doximity (NYSE:DOCS) has observed the following analyst ratings:
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash.
Mid-Day Market Update: Crude Oil Edges Higher As EIA Reports Drop In Crude Oil Inventories
US stocks remained higher on Wednesday, with the Dow Jones surging more than 250 points.
Mid-Morning Market Update: Markets Open Higher; Nasdaq Gains Over 1%
US stocks opened on strong note on Wednesday, while the Nasdaq Composite surging more than 1% this morning.
Raymond James Maintains Outperform on Doximity, Lowers Price Target to $60
Raymond James analyst Brian Peterson maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target from $80 to $60.
Why Doximity Shares Are Trading Higher Premarket Today?
Doximity Inc (NYSE: DOCS) posted Q3 FY22 sales of $9
Doximity Reports Purchase Of Amion, No Terms Disclosed
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Amion, a leading on-call physician scheduling site. Amion manages nearly 200,000 physician
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell
• Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
EXCLUSIVE: Looking Back On The Best And Worst IPOs Of 2021 With IPO Warriors
2021 was a record year for IPOs. More than 1,000 companies made public debuts, raising about $315 billion in the process.
The previous record of about $200 billion was set during the internet bubble in 2000, IPO Warrior's Matt Hammond said Tuesday on "Benzinga Live."